#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
CS
proLékaře.cz / Journals / Gastroenterology and Hepatology / 2023 - 1

Tofacitinib – is it time for a change in treatment in ulcerative colitis?

Czech version

Published in: Gastroent Hepatol 2023; 77(1): 78-81
Category:

Labels
Paediatric gastroenterology Gastroenterology and hepatology Surgery
Biological therapy of ulcerative colitis during pregnancy
Complicated course of IBD in pregnancy
On the question of the interchangeability of monoclonal bio similar antibodies in the treatment of immune-mediated infl ammatory diseases
Gastrointestinal dysfunctions and their influence on the quality of life in aging adults with spinal cord injury
Autoimmune hepatitis after vaccination against COVID-19
The selection from international journals
Therapeutic monitoring of bio­logics: on the way to personalized medicine
17th educational and discussion gastroenterology days
Professor Ryska has passed away, his legacy remains
Assoc. Prof. Igor Kajaba, MD, PhD.
Kreditovaný autodidaktický test
Overview of the most common skin adverse reactions of bio­logical treatment in patients with inflammatory bowel disease – part 1
Fatal course of an infl ammatory disease
Two years of the COVID-19 pandemic in the population of Czech patients with infl ammatory bowel disease treated with bio logical therapy – experience of the tertiary IBD center
Primary signet ring cell adenocarcinoma as a rare cause of colonic stenosis in a young patient with Crohn’s disease – the case report
Editorial
Epidemiological and demographic characteristics of individuals with irritable bowel syndrome based on the Rome III vs. Rome IV criteria in the Northern part of Serbia
Editorial
Article was published in

Gastroenterology and Hepatology

Issue 1
2023 Issue 1
Most read in this issue
Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#